Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 21696834)

1.

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.

Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H.

Trends Neurosci. 2011 Aug;34(8):430-42. doi: 10.1016/j.tins.2011.05.005. Epub 2011 Jun 21.

2.

Structural imaging in early pre-states of dementia.

Smith CD.

Biochim Biophys Acta. 2012 Mar;1822(3):317-24. doi: 10.1016/j.bbadis.2011.07.002. Epub 2011 Jul 14. Review.

3.

Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.

Forlenza OV, Diniz BS, Teixeira AL, Stella F, Gattaz W.

Rev Bras Psiquiatr. 2013 Jul-Sep;35(3):284-94. doi: 10.1590/1516-4446-2012-3505. Review.

4.

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.

van Rossum IA, Visser PJ, Knol DL, van der Flier WM, Teunissen CE, Barkhof F, Blankenstein MA, Scheltens P.

J Alzheimers Dis. 2012;29(2):319-27. doi: 10.3233/JAD-2011-111694.

PMID:
22233766
5.

Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Morris JC.

Arch Neurol. 2012 Jun;69(6):700-8. doi: 10.1001/archneurol.2011.3152.

6.

Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.

Willette AA, Calhoun VD, Egan JM, Kapogiannis D; Alzheimer׳s Disease Neuroimaging Initiative.

Psychiatry Res. 2014 Nov 30;224(2):81-8. doi: 10.1016/j.pscychresns.2014.08.005. Epub 2014 Aug 17.

PMID:
25194437
7.

Advances in the early detection of Alzheimer's disease.

Nestor PJ, Scheltens P, Hodges JR.

Nat Med. 2004 Jul;10 Suppl:S34-41. Review.

PMID:
15298007
8.

Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection.

Risacher SL, Saykin AJ.

Annu Rev Clin Psychol. 2013;9:621-48. doi: 10.1146/annurev-clinpsy-050212-185535. Epub 2013 Jan 7. Review.

9.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Review. French.

PMID:
22579080
11.

[Use of cerebrospinal fluid (CSF) biomarkers for Alzheimer's type dementia: diagnosis in mild cognitive impairment].

Verhey FR, Visser PJ.

Ned Tijdschr Geneeskd. 2013;157(11):A5596. Review. Dutch.

PMID:
23484512
12.

Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease.

Ikram MK, Cheung CY, Wong TY, Chen CP.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25. Review.

PMID:
22733082
13.

Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.

Trzepacz PT, Yu P, Sun J, Schuh K, Case M, Witte MM, Hochstetler H, Hake A; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2014 Jan;35(1):143-51. doi: 10.1016/j.neurobiolaging.2013.06.018. Epub 2013 Aug 15.

PMID:
23954175
14.

Diagnosis and biomarkers of predementia in Alzheimer's disease.

Forlenza OV, Diniz BS, Gattaz WF.

BMC Med. 2010 Dec 22;8:89. doi: 10.1186/1741-7015-8-89. Review.

15.

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.

Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.

PMID:
21893661
16.

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.

Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H.

Alzheimers Dement. 2014 May;10(3):381-92. doi: 10.1016/j.jalz.2013.04.506. Epub 2013 Jul 11. Review.

PMID:
23850330
17.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
18.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

PMID:
15324364
19.

A critical discussion of the role of neuroimaging in mild cognitive impairment.

Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO.

Acta Neurol Scand Suppl. 2003;179:52-76. Review. Erratum in: Acta Neurol Scand Suppl. 2003 Jul;108(1):68.

PMID:
12603252
20.

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.

Palmqvist S, Hertze J, Minthon L, Wattmo C, Zetterberg H, Blennow K, Londos E, Hansson O.

PLoS One. 2012;7(6):e38639. doi: 10.1371/journal.pone.0038639. Epub 2012 Jun 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk